Omics, MDx Stocks Rise 5 Percent in June Led by Exact Sciences, Sequenom, PacBio, and GenMark | GenomeWeb

NEW YORK (GenomeWeb) – After a mixed picture in May, shares of firms in the omics research tools and MDx space rebounded in June as the GenomeWeb Daily News Index improved by more than 5 percent month over month.

Exact Sciences (+26 percent) paced the gainers, followed by Sequenom (+26 percent), Pacific Biosciences (+25 percent), and GenMark Diagnostics (+23 percent).

Vermillion (-4 percent) and CombiMatrix (-4 percent) were the biggest decliners in June.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."